Non-Controlling Interests
EquityEli Lilly Non-Controlling Interests decreased by 24.5% to $57.50M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 28.7%, from $80.70M to $57.50M. Over 4 years (FY 2020 to FY 2024), Non-Controlling Interests shows a downward trend with a -18.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ3 2025
How to read this metric
The presence of this metric indicates that a portion of the reported consolidated net assets and income belongs to third parties, not the parent company's shareholders.
Detailed definition
The portion of equity in a subsidiary that is not owned by the parent company. This occurs when a company owns more than...
Peer comparison
Common in companies that expand through joint ventures or partial acquisitions, such as global energy or manufacturing firms.
Metric ID:
noncontrolling_interestsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $219.10M | $197.10M | $175.60M | $131.20M | $114.50M | $95.80M | $125.60M | $104.50M | $85.50M | $87.00M | $91.80M | $85.20M | $73.50M | $80.70M | $79.50M | $82.00M | $76.20M | $57.50M |
| QoQ Change | — | -10.0% | -10.9% | -25.3% | -12.7% | -16.3% | +31.1% | -16.8% | -18.2% | +1.8% | +5.5% | -7.2% | -13.7% | +9.8% | -1.5% | +3.1% | -7.1% | -24.5% |
| YoY Change | — | — | — | — | -47.7% | -51.4% | -28.5% | -20.4% | -25.3% | -9.2% | -26.9% | -18.5% | -14.0% | -7.2% | -13.4% | -3.8% | +3.7% | -28.7% |
Range$57.50M – $219.10M
CAGR-27.0%
Avg YoY Growth-20.8%
Median YoY Growth-19.4%
Current Streak2 quarters decline
Non-Controlling Interests at Other Companies
Frequently Asked Questions
- What is Eli Lilly's non-controlling interests?
- Eli Lilly (LLY) reported non-controlling interests of $57.50M in Q3 2025.
- How has Eli Lilly's non-controlling interests changed year-over-year?
- Eli Lilly's non-controlling interests decreased by 28.7% year-over-year, from $80.70M to $57.50M.
- What is the long-term trend for Eli Lilly's non-controlling interests?
- Over 4 years (2020 to 2024), Eli Lilly's non-controlling interests has grown at a -18.9% compound annual growth rate (CAGR), from $183.60M to $79.50M.
- What does non-controlling interests mean?
- The portion of a company's subsidiaries that is owned by outside partners rather than the company itself.